For the years ended December 31, 2011, 2012 and 2013, product sales revenue included the following (in thousands): | | | | | | | | | | | | | | | | Year Ended December 31, | | | 2011 | | 2012 | | 2013 | Physical sale of refined products | | $ | 870,007 |
| | $ | 833,581 |
| | $ | 755,266 |
| NYMEX contract adjustments: | | | | | | | Change in value of NYMEX contracts that did not qualify for hedge accounting treatment and the effective portion of gains and losses of matured NYMEX contracts that qualified for hedge accounting treatment associated with our butane blending and fractionation activities(1) | | (4,330 | ) | | (30,270 | ) | | (10,586 | ) | Change in value of NYMEX contracts that did not qualify for hedge accounting treatment associated with the Houston-to-El Paso pipeline section linefill working inventory(1) | | (11,149 | ) | | (3,940 | ) | | — |
| Other | | — |
| | 11 |
| | (11 | ) | Total NYMEX contract adjustments | | (15,479 | ) | | (34,199 | ) | | (10,597 | ) | Total product sales revenue | | $ | 854,528 |
| | $ | 799,382 |
| | $ | 744,669 |
|
(1) The associated refined products for these activities are, to the extent still owned as of the statement date, or were, to the extent no longer owned as of the statement date, classified as inventory in current assets on our consolidated balance sheets. |